Enterprise Europe Network

MEDICA Healthcare Brokerage Event 2026

16 – 29 Nov 2026 | Düsseldorf, Germany

Register
Register
Register

Instant NanoBiosensors B.V.

Medical Device Manufacturer

www.instantnano.com/Utrecht, Netherlands
2 profile visits

About

Instant NanoBiosensors Co., Ltd. (INB) is a biotechnology company focused on two distinct business areas: genomics and protein biomarker analysis, each supported by independent proprietary technologies and product platforms.

A.INVISION INLab NGS Solution
The INVISION INLab NGS Solution integrates the complete Sample-to-Report NGS workflow. INB develops and manufactures the key components of the workflow, including automated nucleic acid extraction systems, NGS library preparation workstations, targeted NGS panels, and automated bioinformatics and reporting software. By integrating these components into a standardized workflow, INLab enables laboratories to streamline NGS testing, reduce manual operations, and improve workflow consistency and turnaround time.

INB offers targeted NGS panels for applications including solid tumors and liquid tumors. Its INVISION Leukemia NGS Solution, validated by Yale Medical Center and adopted by CAP-accredited laboratories, combines leukemia-related gene panels with INB’s proprietary DimerOff™ technology, which reduces primer-dimer formation and non-specific amplification to improve library quality and sequencing efficiency. The integrated solution supports molecular profiling, treatment decision-making, and disease monitoring for leukemia and other hematological malignancies.

B. Light Sensing Biomarker Analyzer
The Light Sensing Biomarker Analyzer is INB's proprietary optical biosensing platform for antibody analysis and ultra-sensitive protein biomarker detection.

Based on FOPPR® (Fiber-Optic Particle Plasmon Resonance) technology, the platform enables label-free, real-time, and rapid molecular interaction analysis, including binding kinetics and affinity measurements, making it suitable for antibody screening, characterization, and biomarker development.

The platform also supports ultra-sensitive detection of low-abundance protein biomarkers. INB is currently developing a blood-based Alzheimer's disease p-tau217 test based on this technology.

INB's optical biosensing technology has also been adopted in a European Union-funded research program, demonstrating its value in advanced biomarker research and translational applications.

Social media

Areas of activity

LIFE SCIENCE

DiagnosticsLaboratory Equipment

VALUE CHAIN

Business DevelopmentInvestment/ FinancingOEM (Original Equipment Manufacturer)ProductionSales & Distribution

MEDICINE

Cytology, Cancerology, OncologyDiagnostics, Diagnosis

THERAPEUTIC AREA

HematologyImmunologyNeurologyOncology

Representatives

President

Instant NanoBiosensors B.V.

Marketplace (4)

  • Product

    INVISION INLAB NGS SOLUTION: End-to-End Sample-to-Report Integration

    The INVISION INLab NGS Solution integrates nucleic acid extraction, library preparation, targeted NGS panels, and bioinformatics reporting into a standardized workflow, reducing manual steps and turnaround time while improving consistency.

    • Buyer
    • LIFE SCIENCE
    • Investment/Finance
    • INDUSTRIAL BIOTECHNOLOGY
    Author

    President at Instant NanoBiosensors B.V.

    Utrecht, Netherlands

  • Partnership

    OEM/ODM Partnership for INLab NGS Solution

    INB provides OEM/ODM development of reagents, instruments, and software, helping reagent companies integrate their products into automated testing solutions with customized workflows, bioinformatics, and reporting capabilities.

    • Research
    • Business
    • Joint development
    • Technology transfer
    • Testing of technology
    Author

    President at Instant NanoBiosensors B.V.

    Utrecht, Netherlands

  • Product

    Light Sensing Biomarker Analyzer

    INB’s Light Sensing Biomarker Analyzer uses proprietary FOPPR® technology for label-free molecular interaction analysis, rapid antibody characterization, and ultrasensitive protein biomarker detection for Alzheimer's.

    • Buyer
    • LIFE SCIENCE
    • INDUSTRIAL BIOTECHNOLOGY
    Author

    President at Instant NanoBiosensors B.V.

    Utrecht, Netherlands